Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TVTY | Common Stock | Disposed to Issuer | -$15.9M | -488K | -100% | $32.50 | 0 | Jun 28, 2022 | Direct | F1 |
transaction | TVTY | Common Stock | Disposed to Issuer | -$488K | -15K | -100% | $32.50 | 0 | Jun 28, 2022 | By Spouse as Trustee for Monarch Trust | F1 |
transaction | TVTY | Common Stock | Disposed to Issuer | -$7.8M | -240K | -100% | $32.50 | 0 | Jun 28, 2022 | By Self as Beneficiary of Vita Trust | F1 |
transaction | TVTY | Common Stock | Disposed to Issuer | -$589K | -18.1K | -100% | $32.50 | 0 | Jun 28, 2022 | By Self as Trustee for Sanfilippo Family Trust | F1 |
Anthony Michael Sanfilippo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50. |